David Hoaglin to Endpoint Determination
This is a "connection" page, showing publications David Hoaglin has written about Endpoint Determination.
Connection Strength
0.680
-
Dong G, Huang B, Chang YW, Seifu Y, Song J, Hoaglin DC. The win ratio: Impact of censoring and follow-up time and use with nonproportional hazards. Pharm Stat. 2020 05; 19(3):168-177.
Score: 0.653
-
Kam-Hansen S, Jakubowski M, Kelley JM, Kirsch I, Hoaglin DC, Kaptchuk TJ, Burstein R. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med. 2014 Jan 08; 6(218):218ra5.
Score: 0.027